Since the roles of LPA and S1P receptors in glial activation have been mainly studied in cerebral ischemia and MS, future studies should also focus on whether these receptors can influence the activation of microglia and/or astrocytes in other CNS diseases such as PD, AD, and Huntington’s disease. Here, LPA is linked to myeloid sarcoma.